Construction strategies for developing expression vectors for recombinant monoclonal antibody production in CHO cells

被引:16
作者
Li, Yan-mei [1 ,2 ]
Tian, Zheng-wei [1 ,2 ]
Xu, Dan-hua [1 ,2 ]
Wang, Xiao-yin [1 ,2 ]
Wang, Tian-yun [1 ,2 ]
机构
[1] Xinxiang Med Univ, Dept Biochem & Mol Biol, Jinsui Rd, Xinxiang 453003, Henan, Peoples R China
[2] Xinxiang Med Univ, Int Joint Res Lab Recombiant Pharmaceut Prot Expr, Jinsui Rd, Xinxiang 453003, Henan, Peoples R China
基金
中国国家自然科学基金;
关键词
Recombinant proteins; Monoclonal antibodies; CHO cells; IRES; Furin-2A; LINE; TRANSLATION; MECHANISM; DESIGN; GENES;
D O I
10.1007/s11033-018-4351-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent years have seen the use of recombinant proteins in the treatment of different diseases. Among them, monoclonal antibodies (mAbs) are currently the fastest growing class of bio-therapeutic recombinant proteins. Chinese hamster ovary (CHO) cells are the most commonly used host cells for production of these recombinant mAbs. Expression vectors determine the expression level and quality of recombinant mAbs. Currently, few construction strategies for recombinant mAbs expression vectors in CHO cells have been developed, including monocistronic vector, multiple-promoter expression vector, and tricistronic vector mediated by internal ribosome entry site (IRES) or Furin-2A element. Among them, Furin-2A-mediated vector is an effective approach due to advantages of high "self-cleavage" efficiency, and equal expression of light and heavy chains from a single open reading frame. Here, we have reviewed the progress in development of different strategies for constructing recombinant mAb expression vectors in CHO cells and its potential advantages and disadvantages.
引用
收藏
页码:2907 / 2912
页数:6
相关论文
共 50 条
  • [41] IRES-mediated Tricistronic vectors for enhancing generation of high monoclonal antibody expressing CHO cell lines
    Ho, Steven C. L.
    Bardor, Muriel
    Feng, Huatao
    Mariati
    Tong, Yen Wah
    Song, Zhiwei
    Yap, Miranda G. S.
    Yang, Yuansheng
    JOURNAL OF BIOTECHNOLOGY, 2012, 157 (01) : 130 - 139
  • [42] Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants
    Beck, Alain
    Nowak, Christine
    Meshulam, Deborah
    Reynolds, Kristina
    Chen, David
    Pacardo, Dennis B. B.
    Nicholls, Samantha B. B.
    Carven, Gregory J. J.
    Gu, Zhenyu
    Fang, Jing
    Wang, Dongdong
    Katiyar, Amit
    Xiang, Tao
    Liu, Hongcheng
    ANTIBODIES, 2022, 11 (04)
  • [43] Optimization of protein-free culture medium for CHO cells producing monoclonal antibody
    Zhao, L. (zhaoliang@ecust.edu.cn), 1600, Zhejiang University (27): : 96 - 101
  • [44] Identification and characterization of a -1 reading frameshift in the heavy chain constant region of an IgG1 recombinant monoclonal antibody produced in CHO cells
    Lian, Zhirui
    Wu, Qindong
    Wang, Tongtong
    MABS, 2016, 8 (02) : 358 - 370
  • [45] Combinatorial treatment with lithium chloride enhances recombinant antibody production in transiently transfected CHO and HEK293E cells
    Che Lin Kim
    Tae Kwang Ha
    Gyun Min Lee
    Biotechnology and Bioprocess Engineering, 2016, 21 : 667 - 675
  • [46] Use of a plackett-burman statistical design to determine the effect of selected amino acids on monoclonal antibody production in CHO cells
    Gonzalez-Leal, I. J.
    Carrillo-Cocom, L. M.
    Ramirez-Medrano, A.
    Lopez-Pacheco, F.
    Bulnes-Abundis, D.
    Webb-Vargas, Y.
    Alvarez, M. M.
    BIOTECHNOLOGY PROGRESS, 2011, 27 (06) : 1709 - 1717
  • [47] A Stable CHO K1 Cell Line for Producing Recombinant Monoclonal Antibody Against TNF-α
    Gupta, Kritika
    Modi, Deepak
    Jain, Ratnesh
    Dandekar, Prajakta
    MOLECULAR BIOTECHNOLOGY, 2021, 63 (09) : 828 - 839
  • [48] An Empirical Modeling Platform to Evaluate the Relative Control Discrete CHO Cell Synthetic Processes Exert Over Recombinant Monoclonal Antibody Production Process Titer
    McLeod, Jane
    O'Callaghan, Peter M.
    Pybus, Leon P.
    Wilkinson, Stephen J.
    Root, Tracy
    Racher, Andrew J.
    James, David C.
    BIOTECHNOLOGY AND BIOENGINEERING, 2011, 108 (09) : 2193 - 2204
  • [49] A Stable CHO K1 Cell Line for Producing Recombinant Monoclonal Antibody Against TNF-α
    Kritika Gupta
    Deepak Modi
    Ratnesh Jain
    Prajakta Dandekar
    Molecular Biotechnology, 2021, 63 : 828 - 839
  • [50] CHO cells in biotechnology for production of recombinant proteins: current state and further potential
    Kim, Jee Yon
    Kim, Yeon-Gu
    Lee, Gyun Min
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2012, 93 (03) : 917 - 930